We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Declining Sales to Hurt JAKKS Pacific (JAKK) in Q1 Earnings
Read MoreHide Full Article
JAKKS Pacific, Inc. (JAKK - Free Report) is scheduled to report first-quarter 2019 results on May 9, after the market closes.
Not exempting the fate of all traditional toymakers, the company is facing a dearth of consumer demand for quite some time now. Notably, it has recorded dismal sales over the past few quarters due to the Toys ‘R’ Us liquidation and this trend is likely to have continued in the first quarter of 2019. Also, earnings may have been affected in the to-be-reported quarter due to higher expenses.
Let us see how the company’s top and bottom lines will shape up in the first quarter.
Top Line to Continue to Decline
After the Toys “R” Us liquidation, JAKKS Pacific has been witnessing a sales slump across the majority of brands. In fact, the company’s net revenues in 2018 declined 7.4% year over year primarily due to the liquidation.We believe that the effect of this liquidation will linger further as Toys “R” Us was the last major chain, fully dedicated to selling toys.
Subsequently, the Zacks Consensus Estimate for the company’s first-quarter revenues is pegged at $78.7 million, reflecting a 15.4% decline from the year-ago quarter.
High Costs to Hurt Bottom line
Although JAKKS Pacific’s initiatives, including product launches and the shift toward more technology-driven toys to revive brands for boosting sales, would aid profits in the long term, costs related to those initiatives might prove detrimental in the near term. We expect this trend to have continued in the first quarter of 2019. The Zacks Consensus Estimate pegs first-quarter loss at 56 cents. The company reported loss of 85 cents in the prior-year quarter.
What Does the Zacks Model Predict?
Per the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Stocks carrying a Zacks Rank #4 or 5 (Sell-rated) are best avoided, especially if they have a negative Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
JAKKS Pacific has an Earnings ESP of 0.00% and a Zacks Rank #2, a combination that suggests that the company is unlikely to beat estimates in this quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks With Favorable Combinations
Here are a few stocks from the Consumer Discretionary sector that investors may consider as our model shows that these have the right combination of elements to post an earnings beat in the first quarter:
Deckers Outdoor (DECK - Free Report) has an Earnings ESP of +53.19% and it currently carries a Zacks Rank #3.
H&R Block (HRB - Free Report) has an Earnings ESP of +2.31% and a Zacks Rank #3 at present.
Nike (NKE - Free Report) currently has an Earnings ESP of +2.13% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Declining Sales to Hurt JAKKS Pacific (JAKK) in Q1 Earnings
JAKKS Pacific, Inc. (JAKK - Free Report) is scheduled to report first-quarter 2019 results on May 9, after the market closes.
Not exempting the fate of all traditional toymakers, the company is facing a dearth of consumer demand for quite some time now. Notably, it has recorded dismal sales over the past few quarters due to the Toys ‘R’ Us liquidation and this trend is likely to have continued in the first quarter of 2019. Also, earnings may have been affected in the to-be-reported quarter due to higher expenses.
Let us see how the company’s top and bottom lines will shape up in the first quarter.
Top Line to Continue to Decline
After the Toys “R” Us liquidation, JAKKS Pacific has been witnessing a sales slump across the majority of brands. In fact, the company’s net revenues in 2018 declined 7.4% year over year primarily due to the liquidation.We believe that the effect of this liquidation will linger further as Toys “R” Us was the last major chain, fully dedicated to selling toys.
Subsequently, the Zacks Consensus Estimate for the company’s first-quarter revenues is pegged at $78.7 million, reflecting a 15.4% decline from the year-ago quarter.
High Costs to Hurt Bottom line
Although JAKKS Pacific’s initiatives, including product launches and the shift toward more technology-driven toys to revive brands for boosting sales, would aid profits in the long term, costs related to those initiatives might prove detrimental in the near term. We expect this trend to have continued in the first quarter of 2019. The Zacks Consensus Estimate pegs first-quarter loss at 56 cents. The company reported loss of 85 cents in the prior-year quarter.
What Does the Zacks Model Predict?
Per the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Stocks carrying a Zacks Rank #4 or 5 (Sell-rated) are best avoided, especially if they have a negative Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
JAKKS Pacific has an Earnings ESP of 0.00% and a Zacks Rank #2, a combination that suggests that the company is unlikely to beat estimates in this quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks With Favorable Combinations
Here are a few stocks from the Consumer Discretionary sector that investors may consider as our model shows that these have the right combination of elements to post an earnings beat in the first quarter:
Deckers Outdoor (DECK - Free Report) has an Earnings ESP of +53.19% and it currently carries a Zacks Rank #3.
H&R Block (HRB - Free Report) has an Earnings ESP of +2.31% and a Zacks Rank #3 at present.
Nike (NKE - Free Report) currently has an Earnings ESP of +2.13% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>